Other highlights in the May 15 issue of JNCI
May 14, 2002- Modified Adenoviral Therapy May Help Shrink Ovarian Tumors: The effectiveness of adenovirus-based gene therapy for advanced cancers has been limited because many cancer cells lack the receptor needed for viral infection. Using a modified adenoviral vector (RGDTKSSTR) that does not depend on the adenovirus receptor, Akseli Hemminki, M.D., Ph.D., of the University of Alabama at Birmingham, and his coworkers showed that mouse models of human ovarian cancer injected with this modified virus had smaller ovarian tumors and lived longer than mouse models injected with control viruses. The authors conclude that RGDTKSSTR may be a useful gene delivery tool for testing in ovarian cancer trials.
- Growth Factor May Be Associated with Decreased Lung Cancer Risk:Insulin-like growth factor I (IGF-I) stimulates cell growth in the lungs while its binding protein, IGF-binding protein 3 (IGFBP-3), inhibits cell growth. In a prospective study among men in China, Stephanie J. London, M.D., Dr.P.H., of the National Institute of Environmental Health Sciences, and her coworkers determined whether baseline serum levels of IGF-I and IGFBP-3 were associated with subsequent lung cancer risk.
The authors compared serum levels of IGF-I and IGFBP-3 in 230 men who developed lung cancer during the course of the study and in 740 control subjects, and found that men with increased levels of IGFBP-3 at baseline had a reduced risk of lung cancer, whereas increased levels of IGF-I was not associated with increased lung cancer risk. The authors point out that the association was strongest in men with a smoking history. - Environmental Factors May Influence Degree of DNA Methylation: Certain patterns of DNA methylation in tumor suppressor genes have been associated with cancer. One such pattern is the CpG island methylator phenotype (CIMP), which has been found in several cancers. Lanlan Shen and Jean-Pierre Issa, M.D., of the University of Texas M. D. Anderson Cancer Center in Houston, and their coworkers looked at gene methylation within hepatocellular carcinoma tumors from patients in different countries. The degree of methylation appeared higher in countries with a higher incidence of hepatocellular carcinoma. The authors suggest that environmental factors may influence the degree of methylation of multiple genes in hepatocellular carcinoma.
- Delivery of Antitumor Protein Enhanced With Electro-Gene Therapy: Interleukin-12 (IL-12) protein therapy has been shown to stimulate an antitumor response; however attempts to deliver the gene into tumors have not been very effective. Shulin Li, Ph.D., of the Henry Ford Health System in Detroit, Mich., and his coworkers used electric pulses to deliver the IL-12 gene into mouse tumor models and found that the treatment eradicated tumor growth in 40% of the mice, as well as triggered an immune response. Moreover, the antitumor memory lasted more than 11 months. The authors conclude that IL-12 electro-gene therapy could potentially be applicable in the treatment of electrode-accessible cancers, such as head and neck cancers.
-end-
Attribution to the Journal of the National Cancer Institute is requested in all news coverage.Journal of the National Cancer Institute
Related Lung Cancer Articles from Brightsurf:
State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.
The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.
'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.
Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.
Read More: Lung Cancer News and Lung Cancer Current Events
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.
The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.
'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.
Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.
Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.